To include your compound in the COVID-19 Resource Center, submit it here.

Effector expands series B round

Effector Therapeutics Inc. (San Diego, Calif.) raised an additional $16 million in series

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE